Who owns CATALYST PHARMACEUTICALS, INC. (CPRX)? Elite investor 13F holders
5 tracked elite investors reported holding CATALYST PHARMACEUTICALS, INC as of 2026-06-30, including Renaissance Technologies LLC, Third Avenue Management, D.E. Shaw, Gotham Asset Management, GAMCO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | CATALYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 67136900.00 USD | 2136077.000000 | Shares | reduce | Original filing |
| Third Avenue Management | CATALYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 6605360.00 USD | 210161.000000 | Shares | hold | Original filing |
| D.E. Shaw | CATALYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4228309.00 USD | 134531.000000 | Shares | add | Original filing |
| Gotham Asset Management | CATALYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1295419.00 USD | 41216.000000 | Shares | reduce | Original filing |
| Tudor Investment | CATALYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| GAMCO | CATALYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 440020.00 USD | 14000.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.